@article{943251268840497ea7223e392d45fea0,
title = "First-in-human study of ALK201, a FGFR2b-targeting antibody-drug conjugate (ADC) for patients (pts) with advanced solid tumors.",
author = "Dan-yun Ruan and Qi Dang and Suxia Luo and Yanqiu Zhao and Udit Nindra and Tang, \{Shou Qing\} and Haiping Jiang and Jian Liu and Parsonson, \{Andrew Ohyama\} and Morris, \{Michelle Frances\} and Lin Xie and Xinjun Liang and Lilin Chen and Rui Meng and Sijuan Ding and Huaqiu Shi and Yong Fang and Meredith Pelster and Yongsheng Li and Rui-Hua Xu",
year = "2026",
month = jun,
day = "1",
doi = "10.1200/JCO.2026.44.16\_suppl.3025",
language = "English",
volume = "44",
journal = "Journal of Clinical Oncology",
issn = "1527-7755",
publisher = "Lippincott Williams and Wilkins",
number = "16 Supplement",
note = "2026 American Society of Clinical Oncology (ASCO) Annual Meeting ; Conference date: 29-05-2026 Through 02-06-2026",
}